Hormone-based drugs taken during menopause will no longer carry a bold warning label, the Food and Drug Administration announced this week.

The so-called "black box" label that is being removed is the strongest warning for prescription drugs that the FDA can require.

What they're saying:

FDA Commissioner Marty Makary and some other doctors have long criticized the current warning for these drugs as outdated and unnecessary. Many doctors — and pharmaceutical companies — have called for removing or revising the label, which they say discourages prescriptions and scares off women who could benefit.

"We’re challenging outdated thinking and recommitting to evidence-based medicine that empowers rather than restricts," Health Secretary Robert F. Kennedy Jr. said in introducing the update.

See Full Page